Iwona Skrzekowska-Baran, owner and CEO of Pharm&Med, a young, exciting Polish consultancy that is helping clients to transform evidence, policy insights, and market intelligence into effective market access strategies. She highlights the niche approach of the company to the marketplace, challenges in Polish healthcare and the future aspirations of Pharm&Med as their footprint continues to grow.
You founded Pharm&Med a few months ago. Could you introduce yourself and the company to our international audience?
"Poland does not reimburse innovative drugs to a large extent, and this is a dominant reason why it is important to explain thoroughly the peculiarities of the Polish market to companies"
